Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionWalleye Trading LLC
Latest Disclosed Ownership1,697 shares
Latest Disclosed Value $ 223,563
Walleye Trading LLC ownership in NBIX / Neurocrine Biosciences, Inc.

On May 8, 2026 - Walleye Trading LLC filed a 13F-HR form disclosing ownership of 1,697 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $223,563 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 500 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 239.40% during the quarter.

Walleye Trading LLC has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 8,000 of underlying shares valued at $1,053,920 USD and put options representing 3,700 of underlying shares valued at $487,438 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,697 1,197 239.40 224 218.57 0.0004
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 500 500 71 0.0001
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -1,988 -100.00 0 -100.00
2025-02-13 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,988 1,549 352.85 271 442.00 0.0006
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 439 439 51 0.0001
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -40 -100.00 0 -100.00
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 40 40 6 0.0000
2022-08-08 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -6,519 -100.00 0 -100.00
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,519 4,573 234.99 611 268.07 0.0020
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,946 1,499 335.35 166 286.05 0.0005
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 447 -2,366 -84.11 43 -84.31 0.0002
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,813 -454 -13.90 274 -13.84 0.0011
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,267 1,974 152.67 318 156.45 0.0014
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,293 -4,683 -78.36 124 -78.43 0.0005
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,976 5,976 575 0.0031
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -32,262 -100.00 0 -100.00
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 32,262 31,468 3,963.22 2,792 3,184.71 0.0216
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 794 794 85 0.0006
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -13,400 -100.00 0 -100.00
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,400 12,179 997.46 957 538.00 0.0070
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,221 1,221 150 0.0008
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -75 -100.00 0 -100.00
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 75 75 3 0.0000
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -100 -100.00 0 -100.00
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 100 100 6 0.0001
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -200 -100.00 0 -100.00
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 200 10 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Call 8,000 7,900.00 1,054 7,421.43 n/a n/a n/a
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Call 100 14 n/a n/a n/a
2025-02-13 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 2,600 300 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Call 7,500 581.82 1,034 618.06 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Call 1,100 145 n/a n/a n/a
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Call 2,200 263 n/a n/a n/a
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Call 3,900 11.43 332 -1.19 n/a n/a n/a
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Call 3,500 150.00 336 147.06 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Call 1,400 -85.42 136 -85.44 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Call 9,600 231.03 934 235.97 n/a n/a n/a
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Call 2,900 -90.17 278 -90.20 n/a n/a n/a
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Call 29,500 16.60 2,837 -8.10 n/a n/a n/a
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Call 25,300 -34.46 3,087 -7.60 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Call 38,600 13.86 3,341 -8.32 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Call 33,900 79.37 3,644 113.98 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Call 18,900 -57.05 1,703 -54.16 n/a n/a n/a
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Call 44,000 89.66 3,715 81.75 n/a n/a n/a
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 23,200 -13.43 2,044 6.79 n/a n/a n/a
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Call 26,800 185.11 1,914 65.57 n/a n/a n/a
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Call 9,400 77.36 1,156 121.88 n/a n/a n/a
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Call 5,300 521 n/a n/a n/a
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Call 100 4 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Put 3,700 0.00 487 -7.06 n/a n/a n/a
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Put 3,700 525 n/a n/a n/a
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Put 100 -95.00 14 -94.35 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Put 2,000 230 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Put 1,200 0.00 166 4.43 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Put 1,200 158 n/a n/a n/a
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Put 600 0.00 51 -12.07 n/a n/a n/a
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Put 600 -40.00 58 -40.21 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Put 1,000 -93.55 97 -93.56 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Put 15,500 1,092.31 1,507 1,105.60 n/a n/a n/a
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Put 1,300 -91.45 125 -91.45 n/a n/a n/a
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Put 15,200 -51.13 1,462 -61.47 n/a n/a n/a
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Put 31,100 -41.32 3,794 -17.29 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Put 53,000 310.85 4,587 230.71 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Put 12,900 279.41 1,387 353.27 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Put 3,400 -33.33 306 -29.00 n/a n/a n/a
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Put 5,100 -84.36 431 -84.99 n/a n/a n/a
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Put 32,600 -10.19 2,872 10.80 n/a n/a n/a
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Put 36,300 202.50 2,592 75.73 n/a n/a n/a
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Put 12,000 1,614.29 1,475 2,037.68 n/a n/a n/a
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Put 700 69 n/a n/a n/a
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Put 200 8 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.